Recent Zambian research into the antiretroviral (ARV) drug, nevirapine, has found that it does not compromise the long-term health of women, contradicting earlier studies conducted in Uganda. Nevirapine is widely used in Africa to prevent mother-to-child HIV transmission. A single dose of nevirapine is given to the mother before birth and to her baby after birth.